outlicensing
Strategy, Solution & Spend: Global Pharmaceutical Serialisation in 2014
March 21 by Pharmaceuticals & Biotechnology EditorPharma IQ presents the latest research from the from the Global Pharmaceutical Serialisation and Traceability Survey 2014 in this handy infographic. Get a first look at 2014 trends for serialisation...
Schutz sensibler Informationen in der Life Sciences Branche
January 12 by Pharmaceuticals & Biotechnology EditorThis whitepaper from Brainloop is an excellent reading companion to their Intellectual Property Protection Webinar. As any Out-licensing project manager will testify, protecting your intellectual...
Pharmaceutical Intellectual Property Rights: What you need to know
January 02 by Pharma IQPharmaceutical Intellectual Property Rights Webinar The webinar discusses What you need to know about Intellectual Property Rights with regards to outlicensing in the pharmaceutical industry. As a...
Pharmaceutical Out Licensing: The Essential Guide to Protecting Your Intellectual Property in Pharmaceutical Out Licensing
December 30 by Pharma IQKeeping confidential documents secure is vital, not only in an Out-Licensing situation but across the entire organization, across multiple cooperating organizations and in all your processes and proje...
Intellectual Property Protection Solutions for Pharma and Biotech - Part 2
November 10 by Pharma IQIn part one of our Brainloop interview we introduced BrigitteEhret, Director at Brainloop who explained some of the questions pharma professionals have about IP protection when partnerships demand d...
Don’t Lose Your Intellectual Property
October 15 by Andrea CharlesIn this Pharma IQ podcast David Topping, Vice President Global Marketing, Brainloop, and Andrea Charles from Pharma IQ, discuss what is out-licensing and the steps companies need to take to pro...
Intellectual Property Protection Solutions for Pharma and Biotech
October 09 by Pharma IQIntellectual property is the life science industry’s most important capital. It forms the basis of a product’s market authorization, as well as of successful partnership, license and due...
